CrisprBits: Biotech startup CrisprBits develops platform to test antibiotic resistance

Share via:


CrisprBits, a Bengaluru-based biotech startup, has developed a platform from CRISPR-based molecular diagnostics for early detection of antibiotic resistance in hospital-acquired infections. The startup’s PathCrisp platform can detect resistance in bacterial samples from patients within two hours compared to 24-27 hours through other methods. This can reduce prolonged hospital stays and bring down healthcare costs. “It operates at a constant temperature, eliminating the need for a thermocycler, and works directly on various samples, including…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

admin
admin
Hi! This is Admin.

Popular

More Like this

CrisprBits: Biotech startup CrisprBits develops platform to test antibiotic resistance


CrisprBits, a Bengaluru-based biotech startup, has developed a platform from CRISPR-based molecular diagnostics for early detection of antibiotic resistance in hospital-acquired infections. The startup’s PathCrisp platform can detect resistance in bacterial samples from patients within two hours compared to 24-27 hours through other methods. This can reduce prolonged hospital stays and bring down healthcare costs. “It operates at a constant temperature, eliminating the need for a thermocycler, and works directly on various samples, including…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

admin
admin
Hi! This is Admin.

More like this

This mental health chatbot aims to fill the counseling...

As school districts struggle to support the mental...

China’s Xi Jinping holds rare meet with business leaders...

President Xi Jinping held a rare, highly choreographed...

Apple’s M4 MacBook Air bump may be just around...

Apple is readying its MacBook Air line for...

Popular

Upcoming Events

Startup Information that matters. Get in your inbox Daily!